A detailed history of Brevan Howard Capital Management LP transactions in Ideaya Biosciences, Inc. stock. As of the latest transaction made, Brevan Howard Capital Management LP holds 13,788 shares of IDYA stock, worth $307,334. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13,788
Previous 44,539 69.04%
Holding current value
$307,334
Previous $1.14 Million 80.33%
% of portfolio
0.0%
Previous 0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025

SELL
$16.38 - $26.0 $503,701 - $799,526
-30,751 Reduced 69.04%
13,788 $225,000
Q4 2024

Feb 14, 2025

BUY
$24.79 - $31.98 $748,980 - $966,211
30,213 Added 210.9%
44,539 $1.14 Million
Q3 2024

Nov 14, 2024

BUY
$30.37 - $43.05 $435,080 - $616,734
14,326 New
14,326 $453,000

Others Institutions Holding IDYA

About IDEAYA Biosciences, Inc.


  • Ticker IDYA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,067,700
  • Market Cap $1.07B
  • Description
  • IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase I clinica...
More about IDYA
Track This Portfolio

Track Brevan Howard Capital Management LP Portfolio

Follow Brevan Howard Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brevan Howard Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Brevan Howard Capital Management LP with notifications on news.